ident and CEO of EthiX Associates, a pharmaceutical and biotech consultancy he founded in 1996. He has also served as the President and CEO of GenBioPro, Inc., a specialty biopharmaceutical company focused on the development and marketing of "biosimilar" products, and INSYS Therapeutics, Inc., a privately held biopharmaceutical company with a focus on chemotherapy induced nausea and vomiting, pain management and CNS disorders.
He held the positions of the Chairman, President, and CEO of the Arizona BioIndustry Association from 2004 to 2007.
Mr. McGarity was President and Chief Operating Officer and then Vice Chairman of Pharmaceutical Marketing Services, Inc. from 1991 to 1996.
He was employed by GlaxoSmithKline (then Glaxo) from 1987 to 1991. Over that time he served as Vice President in the Corporate Division; Vice President of National Accounts; Vice President and General Manager of the Glaxo Dermatology group; and Director of Managed Health Care.
From 1981 to 1986, Mr. McGarity worked as Vice President of Sales and Marketing at Westwood Pharmaceuticals, the specialty pharmaceuticals division of Bristol Myers Squibb.
From 1965 to 1981 he was employed by Novartis Pharmaceuticals (then Sandoz) having worked throughout the ranks of their commercial organization as a sales representative, hospital representative, product manager, district manager, and Director of Sales and Marketing in Canada and the United States.
Mr. McGarity is a Board Director at Cypress Biosciences Inc. (CYPB), and also serves on the Boards of several early stage pharma/biotech companies including Apthera, GenBioPro, SynBuild, MedApps, Inc., and Restorative Biosciences. He also sits of the Boards of a number of life science organizations and university programs including the Arizona BioIndustry Association and the Global Advisory Council at Thunderbird School of Global ManagementPage: 1 2 3 4 Related biology technology :1
. SENOMYX ANNOUNCES EXTENSION OF ITS COLLABORATION WITH CAMPBELL SOUP COMPANY2
. Campbell Alliance Brand Management Practice to Present at EyeForPharmas Oncology Summit USA and Oncology Market Access Europe Conference3
. Campbell Alliance Hires Joe Dillon, Expands Business Development Practice4
. Campbell Alliance Sales Practice to Present at CBIs Leadership Summit on Evolving the Pharma Sales Model5
. Nader Naeymi-Rad Appointed Chief Operating Officer at Campbell Alliance6
. Darius Naigamwalla Appointed Senior Vice President and Head of the Brand Management Practice at Campbell Alliance7
. Pharmaceutical Institute, in Collaboration With Campbell Alliance, Releases Second Edition of Breakthrough Book on the Inner Workings of the Pharmaceutical Industry8
. Campbell Alliance Clinical Development Practice to Conduct Two Workshops at 44th DIA Annual Meeting9
. Campbell Alliance Trade and Distribution Practice to Speak at CBIs Commercial Contracts and Chargeback Management Conference10
. Campbell Alliance Sales Practice to Present Workshop at SPBT Annual Conference11
. Campbell Alliance Clinical Development Practice to Present Session on Global EDC Rollout at Clinical Trials Congress, Europe